Co-led Minghui Pharmaceutical's $131M Pre-IPO financing alongside OrbiMed, taking a board seat.
Minghui Pharmaceutical is a global biopharmaceutical company dedicated to developing innovative medicines for the benefit of patients with diseases of largely unmet medical needs
Minghui Pharmaceutical is a global biopharmaceutical company dedicated to developing innovative medicines for the benefit of patients with diseases of largely unmet medical needs.